Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59351 - 59375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	MSH2	4436	downregulated	Piroxicam results in decreased expression of MSH2 mRNA	2p21-p16.3	A23661
Piroxicam	Approved Investigational	MSH6	2956	downregulated	Piroxicam results in decreased expression of MSH6 mRNA	2p16.3	A23661
Piroxicam	Approved Investigational	MSMO1	6307	downregulated	Piroxicam results in decreased expression of MSMO1 mRNA	4q32.3	A23661
Piroxicam	Approved Investigational	MT1F	4494	upregulated	Piroxicam results in increased expression of MT1F mRNA	16q13	A23661
Piroxicam	Approved Investigational	MT1X	4501	downregulated	Piroxicam results in decreased expression of MT1X mRNA	16q13	A23661
Piroxicam	Approved Investigational	MT2A	4502	downregulated	Piroxicam results in decreased expression of MT2A mRNA	16q13	A23661
Piroxicam	Approved Investigational	MX1	4599	downregulated	Piroxicam results in decreased expression of MX1 mRNA	21q22.3	A21015
Piroxicam	Approved Investigational	MXRA5	25878	upregulated	Piroxicam results in increased expression of MXRA5 mRNA	Xp22.33	A21015
Piroxicam	Approved Investigational	MYCBP	26292	downregulated	Piroxicam results in decreased expression of MYCBP mRNA	1p34.3	A23661
Piroxicam	Approved Investigational	NAA15	80155	upregulated	Piroxicam results in increased expression of NAA15 mRNA	4q31.1	A23661
Piroxicam	Approved Investigational	NAB1	4664	downregulated	Piroxicam results in decreased expression of NAB1 mRNA	2q32.2	A23661
Piroxicam	Approved Investigational	NAP1L1	4673	upregulated	Piroxicam results in increased expression of NAP1L1 mRNA	12q21.1	A23661
Piroxicam	Approved Investigational	NASP	4678	downregulated	Piroxicam results in decreased expression of NASP mRNA	1p34.1	A23661
Piroxicam	Approved Investigational	NBR1	4077	downregulated	Piroxicam results in decreased expression of NBR1 mRNA	17q21.31	A23661
Piroxicam	Approved Investigational	NCAPD3	23310	downregulated	Piroxicam results in decreased expression of NCAPD3 mRNA	11q25	A23661
Piroxicam	Approved Investigational	NCAPG	64151	downregulated	Piroxicam results in decreased expression of NCAPG mRNA	4p15.31	A23661
Piroxicam	Approved Investigational	NCAPH	23397	downregulated	Piroxicam results in decreased expression of NCAPH mRNA	2q11.2	A23661
Piroxicam	Approved Investigational	NCK1	4690	downregulated	Piroxicam results in decreased expression of NCK1 mRNA	3q22.3	A23661
Piroxicam	Approved Investigational	NDC80	10403	downregulated	Piroxicam results in decreased expression of NDC80 mRNA	18p11.32	A23661
Piroxicam	Approved Investigational	NDUFA4L2	56901	downregulated	Piroxicam results in decreased expression of NDUFA4L2 mRNA	12q13.3	A21015
Piroxicam	Approved Investigational	NDUFA5	4698	downregulated	Piroxicam results in decreased expression of NDUFA5 mRNA	7q31.32	A23661
Piroxicam	Approved Investigational	NEK9	91754	upregulated	Piroxicam results in increased expression of NEK9 mRNA	14q24.3	A23661
Piroxicam	Approved Investigational	NET1	10276	downregulated	Piroxicam results in decreased expression of NET1 mRNA	10p15.1	A23661
Piroxicam	Approved Investigational	NFE2L1	4779	downregulated	Piroxicam results in decreased expression of NFE2L1 mRNA	17q21.3	A23661
Piroxicam	Approved Investigational	NID2	22795	upregulated	Piroxicam results in increased expression of NID2 mRNA	14q22.1	A21015

Displaying entries 59351 - 59375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability